vimarsana.com
Home
Live Updates
Lenabasum Improved Skin Symptoms, in Small Dermatomyositis T
Lenabasum Improved Skin Symptoms, in Small Dermatomyositis T
Lenabasum Improved Skin Symptoms, in Small Dermatomyositis Trial
In the phase 2 trial, skin biopsies before and after treatment showed significant reductions in inflammatory cytokines relevant to dermatomyositis pathogenesis.
Related Keywords
New York ,
United States ,
University Of Pennsylvania ,
Pennsylvania ,
Hospital For Special Surgery ,
Philadelphia ,
Robert Spiera ,
European Congress ,
National Institutes Of Health ,
Corbus Pharmaceuticals ,
Arthritis Research Therapy ,
Scleroderma Program ,
Cutaneous Dermatomyositis Disease Area ,
Severity Index ,
Total Improvement ,
American College ,
Rheumatology Combined Response Index ,
Diffuse Cutaneous Systemic ,
Special Surgery ,
Corporal Michael ,
Veterans Affairs Medical Center ,
National Institutes ,
Arthritis Research ,
Dermatomyositis ,
Skin Rash ,
Diffuse Sclerosis ,
Childers Disease ,
Iffuse Myelinoclastic Sclerosis ,
Systemic Lupus Erythematosus ,
Sale ,
Immunosuppressive Therapy ,
Immunosuppressive Agents ,
Immunosuppressive Drugs ,
Rug Immunosuppressive ,
Cannabinoid ,
Endocannabinoids ,
Systemic Sclerosis ,
Diffuse Scleroderma ,
Dermatoses ,
Skin Disorders ,
Skin Diseases ,
Drug Development ,
Clinical Research ,
Clinical Trials ,
,